Drawing for A NEW CLINICAL FRANCHISE IN MEDICINE

USPTO serial 85822193

A NEW CLINICAL FRANCHISE IN MEDICINE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LAMOTHE, LESLEY
Law office
TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with A NEW CLINICAL FRANCHISE IN MEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Douglas J. Bucklin

DOUGLAS J. BUCKLIN VOLPE AND KOENIG, P.C.30 S 17TH STPHILADELPHIA, PA 19103-4001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Medical devices; polymer scaffolds; sealants and polymer based implants used either alone or as carriers to administer cells or drugs for regeneration, the repair of central nervous system, spinal cord, and peripheral nerve injury and the treatment of central nervous system, spinal cord, and peripheral nerve diseases or conditions; Medical and scientific research and development and consultation; Medical and scientific research and development and consultation related thereto in the field of polymer implants and scaffolds; regeneration; central nervous system, spinal cord, and peripheral nerve injuries; and central nervous system, spinal cord, and peripheral nerve diseases and conditions; design and fabrication of biomaterials, medical devices, polymer scaffolds, drug delivery and tissue engineering methods and apparatus polymer implants and scaffolds suitable for regeneration or the repair of central nervous system, spinal cord, and peripheral nerve injuryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Nov 15, 2013MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 15, 2013ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 18, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2013DOCKASSIGNED TO EXAMINER—
Jan 18, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance